Innovating antibodies, improving lives
Genmab hosted its 2019 R&D Update and ASH Data Review on December 9. The event was webcast live. You can click here to listen to the replay and click here to download the presentation. This meeting was not an official program of the ASH Annual meeting.
Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.
To register your email address for electronic shareholder communication or to update your settings, log on to the InvestorPortal.
Genmab to Present at the 38th Annual J.P. Morgan Healthcare Conference
Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
Genmab to Hold 2019 R&D Update and ASH Data Review Meeting
More Genmab News Releases